© 2020 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#Descovy

Descoy Tablet held between tow fingers
FDA Approves Once-Daily Descovy for PrEP
Descoy Tablet and Descoy bottle
Descovy (tenofovir alafenamide + emtricitabine) 101
Chart of Approved and Experimental HIV Medications

Southern Health Plans Often Require Preauthorization for PrEP

This bureaucratic requirement may frustrate access to PrEP in the U.S. region where the HIV epidemic is the most severe.

STI Testing Rate for Gay Men on PrEP Is Concerningly Insufficient

This finding calls into question research that has projected that frequent testing among men on PrEP could drive down STI rates.

Taking PrEP Only For a Vacation Is an Option for Gay and Bi Men

A study found that men who started PrEP a week before a vacation and stopped a week after coming home adhered well to the daily regimen.

Major Health Insurer to Stop Covering Descovy to Prevent HIV

A low-cost generic version of Truvada as PrEP will hit the market September 30.

Visibility Matters: HIV Community Experts on the Presence of Trans and Cis Women at AIDS 2020

We asked participants and presenters at the #AIDS2020Virtual what was compelling to them about the gathering. Here are their responses.

STI Rate Did Not Rise During Descovy Versus Truvada PrEP Trial

The study’s authors saw no evidence that the participants increased their sexual risk taking during the 96-week trial.

Treatment: Best for Pregnancy

For pregnant women with HIV, dolutegravir-based regimens are apparently safest.

5,000 Walmart Pharmacies Join National “Ready, Set, PrEP” HIV Program

Safeway and other Albertsons pharmacies will also participate, allowing uninsured clients to fill PrEP prescriptions at no cost.

Coronavirus Delays PrEP Rollout in England

The country’s National Health Service was to provide the HIV prevention drug for free starting this spring.

MISTR and SISTR Help Deliver HIV Prevention PrEP to Texans’ Doorsteps

Scripts and testing don’t require visits to the doc thanks to this partnership between Texas Health Action and the telemedicine portals.
Descoy and Truvada

Yet More Gay and Bi Men May Be Good PrEP Candidates

A greater proportion of this population than previously thought could stand to benefit from pre-exposure prophylaxis.
A sample Gilead Sciences envelope

Gilead Mailers Violated HIV Customers’ Privacy, Claims Lawsuit

Envelopes were sent to people in the pharma giant’s patient assistance program for PrEP.

Adolescents on PrEP May Need More Hands-On Care

The CDC has issued a report detailing considerations for clinicians prescribing PrEP for this population.

Highlights From the First Virtual CROI

A rundown of POZ’s reporting on the 2020 Conference on Retroviruses and Opportunistic Infections

Supply of Our HIV and Hepatitis Meds Is Secure, Says Gilead

The assurance arrives as the pharma giant cuts off most emergency access to remdesivir, a potential COVID-19 treatment.

For Pregnant Women With HIV, Dolutegravir-Based Regimens Are Apparently Safest

Researchers compared regimens prescribed to pregnant women in their second trimester.
Advertisement
Treatment News
Blog: Undetectable = Untransmittable